Quarterly ResultApr 30, 2026, 07:02 AM
LABCORP Q1 Revenue +5.8% to $3.54B; Adj EPS +10.6%; Raises FY26 Guidance
AI Summary
Labcorp Holdings Inc. announced strong first quarter 2026 results, with revenue increasing 5.8% to $3.54 billion and Adjusted EPS growing 10.6% to $4.25. The company raised its full-year 2026 Adjusted EPS guidance, reflecting continued momentum across its Diagnostics and Central Laboratory businesses. Labcorp also highlighted strategic advancements in specialty diagnostics, health system collaborations, and technology innovation, including new AI partnerships and product launches.
Key Highlights
- Q1 2026 Revenue $3.54 billion, up 5.8% from Q1 2025.
- Q1 2026 Diluted EPS $3.35, up 32.8% from Q1 2025.
- Q1 2026 Adjusted EPS $4.25, up 10.6% from Q1 2025.
- Raised full-year 2026 Adjusted EPS guidance to $17.70-$18.35.
- Diagnostics Laboratories Q1 Revenue $2.76 billion, up 5.0%.
- Biopharma Laboratory Services Q1 Revenue $780.6 million, up 8.2%.
- Q1 2026 Operating Cash Flow $191.5 million; Free Cash Flow $70.5 million.
- Invested $202.2 million in acquisitions; repurchased $98.0 million stock.